Hengrui Medicine is a leading pharmaceutical company based in China with a focus on research, development, manufacturing, and commercialization of innovative and high-quality healthcare products. In 1997, it was restructured into a joint-stock company. In 2000 Hengrui was listed on Shanghai Stock Exchange under stock code 600276. The company ranks top 30 worldwide in pharmaceuticals industry by a market capitalization of over 52 billion USD, and is home to more than 21,600 employees worldwide. Hengrui stands out as a front-runner in cancer drugs, contrast agents, and surgical medicines. Hengrui fully owns 8 manufacturing facilities for small and large molecules as well as medical devices. All facilities are approved and audited by NMPA, most also approved by US FDA, EDQM, TGA, and PMDA. We have 11 R&D centers where over 3,000 research staff work on hundreds of therapeutic candidates, many of which may become first-in-class or best-in-class products. Hengrui conducts most of its clinical trials using in-house capabilities that cover medical, trial operations, data management, statistics, and regulatory. This allows us to better control speed and quality. Embracing the spirit of “Honesty and Trustworthiness, Quality First” as a business principle, Hengrui leads the Chinese markets for anti-cancer drugs, surgical anesthetics, specialized infusions, and contrast agents. To date, Hengrui has 10+ products approved in Europe, US, and Japan, covering injectables, oral formulations, and inhalational anesthetics, and has achieved remarkable sales in those markets. Pursuing the concept of “Excelling in Science, Enhancing Life”, Hengrui sees its future as a Chinese multi-national pharmaceutical corporation, and continuously strives for innovation, progress, and achievement of new breakthrough in the healthcare industry.Contact: Mr Dong Wei
Email: [email protected], [email protected]
Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America
Meet us at
CPhI South East Asia 2021
Hall 7-8, IMPACT, Muang Thong Thani, Thailand
4 - 6 August 2021Book a meeting
View Our Exhibitor Profile
WebsiteView All Contact Info
Categories affiliated with Jiangsu Hengrui Medicine Co., Ltd.
Are you a supplier?
Here's what CPhI Online can do for you
- Generate quality leads for your business
- Stay visible for 365 days of the year
- Receive product inquiries and respond to meeting requests directly
- Improve company online presence through Search Engine Optimisation